J.E. Ang
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
-
- Lung Cancer Treatments and Mutations
Papers in
-
- Lung Cancer Treatments and Mutations 3
- Oncology 4
- Colorectal Cancer Treatments and Studies 3
- HER2/EGFR in Cancer Research 3
- Cutaneous Melanoma Detection and Management 1
- Co-authors
- Johann S. de Bono (5 shared papers)James Spicer (3 shared papers)Timothy A. Yap (3 shared papers)Martina Uttenreuther‐Fischer (3 shared papers)Mehdi Shahidi (2 shared papers)Peter Stopfer (1 shared paper)Susan Bell (1 shared paper)Hilary Calvert (1 shared paper)
- Journals
- European Journal of Cancer (2 papers)Molecular Cancer Therapeutics (1 paper)Journal of Clinical Oncology (1 paper)Journal of Thoracic Oncology (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
J.E. Ang
7 papers receiving 337 citations
Peers
Comparison fields: 5 of 35
- Oncology 262
- Pulmonary and Respiratory Medicine 235
- Genetics 26
- Cancer Research 34
- Molecular Biology 142
Countries citing papers authored by J.E. Ang
This map shows the geographic impact of J.E. Ang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.E. Ang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.E. Ang more than expected).
Fields of papers citing papers by J.E. Ang
This network shows the impact of papers produced by J.E. Ang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.E. Ang. The network helps show where J.E. Ang may publish in the future.
Co-authors
The 25 scholars most cited alongside J.E. Ang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 295 | |
| 2 | 2012 | 23 | |
| 3 | 2015 | 22 | |
| 4 | Activity of BIBW 2992, an oral irreversible EGFR/HER2 dual kinase inhibitor, in combination with weekly paclitaxel in non-small cell lung cancer | 2009 | 4 |
| 5 | A phase I study of oral belinostat (PXD101) in patients with advanced solid tumors. | 2007 | 2 |
| 6 | 2024 | 1 | |
| 7 | 2008 | 1 |
About J.E. Ang
J.E. Ang is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Reproductive Medicine and Surgery, having authored 7 papers that have together received 348 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers), HER2/EGFR in Cancer Research (3 papers), Histone Deacetylase Inhibitors Research (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Epigenetics and DNA Methylation (1 paper), Cancer Genomics and Diagnostics (1 paper) and Cutaneous Melanoma Detection and Management (1 paper). The work is most often cited by research in Oncology (262 citations), Pulmonary and Respiratory Medicine (235 citations), Genetics (26 citations), Cancer Research (34 citations) and Molecular Biology (142 citations). J.E. Ang has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Johann S. de Bono, James Spicer, Timothy A. Yap, Martina Uttenreuther‐Fischer, Mehdi Shahidi, Peter Stopfer, Susan Bell, Hilary Calvert, Graham Temple and Laura Vidal. Their work appears in journals such as European Journal of Cancer, Molecular Cancer Therapeutics, Journal of Clinical Oncology, Journal of Thoracic Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.